BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3060147)

  • 1. Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI).
    Fritz H
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():79-82. PubMed ID: 3060147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
    Walter M; Plotnick M; Schechter NM
    Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
    Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
    Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regulation of secretory leukoprotease inhibitor gene expression].
    Kikuchi T; Abe T
    Nihon Rinsho; 1996 Feb; 54(2):405-10. PubMed ID: 8838088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
    Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
    Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
    van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
    J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma.
    Wright CD; Havill AM; Middleton SC; Kashem MA; Lee PA; Dripps DJ; O'Riordan TG; Bevilacqua MP; Abraham WM
    J Pharmacol Exp Ther; 1999 May; 289(2):1007-14. PubMed ID: 10215681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SLPI (secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation.
    Westin U; Polling A; Ljungkrantz I; Ohlsson K
    Biol Chem; 1999 Apr; 380(4):489-93. PubMed ID: 10355635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization.
    Ohlsson K; Bjartell A; Lilja H
    J Androl; 1995; 16(1):64-74. PubMed ID: 7539415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of secretory leukocyte protease inhibitor with proteinase-3.
    Rao NV; Marshall BC; Gray BH; Hoidal JR
    Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
    Boudier C; Cadène M; Bieth JG
    Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses.
    Kido H; Beppu Y; Imamura Y; Chen Y; Murakami M; Oba K; Towatari T
    Biopolymers; 1999; 51(1):79-86. PubMed ID: 10380355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases.
    Kouchi I; Yasuoka S; Ueda Y; Ogura T
    Tokushima J Exp Med; 1993 Jun; 40(1-2):95-107. PubMed ID: 8105562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release.
    Westin U; Lundberg E; Ohlsson K
    Mediators Inflamm; 1998; 7(3):217-20. PubMed ID: 9705610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis.
    Cox SW; Rodriguez-Gonzalez EM; Booth V; Eley BM
    J Periodontal Res; 2006 Oct; 41(5):477-85. PubMed ID: 16953825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.
    Moreau T; Baranger K; Dadé S; Dallet-Choisy S; Guyot N; Zani ML
    Biochimie; 2008 Feb; 90(2):284-95. PubMed ID: 17964057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells.
    Nyström M; Bergenfeldt M; Ljungcrantz I; Lindeheim A; Ohlsson K
    Mediators Inflamm; 1999; 8(3):147-51. PubMed ID: 10704052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa.
    Nyström M; Westin UP; Linder C; Ohlsson K
    Mediators Inflamm; 2001 Oct; 10(5):269-72. PubMed ID: 11759111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mucosal defence capacity against proteolytic leukocyte enzymes.
    Tegner H; Fryksmark U; Ohlsson K
    Eur J Respir Dis Suppl; 1985; 139():62-5. PubMed ID: 3876236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratracheally-instilled antileukoprotease and alpha 1-proteinase inhibitor: effect on human neutrophil elastase-induced experimental emphysema and pulmonary localization.
    Rudolphus A; Kramps JA; Mauve I; Dijkman JH
    Histochem J; 1994 Oct; 26(10):817-24. PubMed ID: 7883591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.